In this work, 3-bromoacetylcoumarin was used as the key starting material for the synthesis of pyran, pyridine, thiophene, thiazole and pyrazole derivatives through its reaction with different reagents. The structures of the newly synthesized compounds were confirmed on the basis of their spectral data and elemental analyses. All of the synthesized compounds were screened for their in vitro anticancer activity against six human cancer cell lines, namely: human gastric cancer (NUGC), human colon cancer (DLD1), human liver cancer (HA22T and HEPG2), nasopharyngeal carcinoma (HONE1), human breast cancer (MCF) and normal fibroblast cells (WI38). The IC50 values (the sample concentration that produces 50% reduction in cell growth) in nanomolars (nM)) showed most of the compounds exhibited significant cytotoxic effect. Among these derivatives, compound 6d showed almost equipotent cytotoxic activity against NUGC (IC50 = 29 nM) compared to the standard CHS 828 (IC50 = 25 nM).
Introduction
Coumarins are a large group of naturally occurring compounds synthesized by numerous plant species as well as by some bacteria and fungi [1, 2] . According to their chemical structure, they belong to the family Hybrid molecules, combining coumarins with different bioactive molecules like: pyran [22] , pyridine [23] , thiazole [24] and pyrazole [25] have recently been reported; these studies resulted in new compounds exhibiting significant anticancer activities.
On the basis of such findings, we report here the synthesis of new compounds containing the benzopyran-2-one nucleus substituted at position 3 with different bioisosteric moieties, such as pyran, pyridine, thiophene, thiazole and pyrazole, derivatives starting from the 3-(2-bromoacetyl)-2H-chromen-2-one (1) or 3-oxo-3-(2-oxo-2H-chromen-3-yl)propanenitrile (8) . All of the newly synthesized compounds have been evaluated for their in vitro cytotoxicity against six human cancer cell lines and normal fibroblast cells.
Results and Discussion

Chemistry
In continuation of our work to synthesize polyfunctionalized biologically active heterocyclic compounds [26] [27] [28] [29] , we investigated the use of the 3-(2-bromoacetyl)-2H-chromen-2-one (1) [30, 31] to synthesize thiophene, thiazole, pyrazole, pyran and pyridine derivatives incorporating a coumarin moiety. The aim of our work is the search for new possible anticancer agents. Thus, the reaction of compound 1 with benzenediazonium chloride gave the hydrazidic halide derivative 2. The analytical and spectral data of compound 2 were the tools of its structure confirmation. Compound 1 reacted with malononitrile in the presence of ammonium acetate in an oil bath at 120 °C to give 2-(2-hydroxy-1-(2-oxo-2H-chromen-3-yl)ethylidene)malononitrile (3) . This reaction involved an initial Knoevenagel condensation followed by hydrolysis of the α-bromo group into an OH moiety.
Next, we moved to studying the reactivity of compound 1 towards thiophene formation via the Gewald's thiophene synthesis [32, 33] . Thus, the reaction of compound 1 with elemental sulfur and either malononitrile or ethyl cyanoacetate in absolute ethanol solution containing triethylamine gave the thiophene derivatives 4a and 4b, respectively. The analytical and spectral data of the latter compounds were the basis of their structural elucidation. Thus, the 1 H-NMR spectrum of compound 4a (as an example) showed the presence of two singlets at δ 3.60, 6.90; corresponding to NH2 (D2O exchangeable) and coumarin H-4 in addition to a multiplet at δ 7.07-7.85; corresponding to the four aromatic protons. Moreover, the 13 C-NMR spectrum showed the presence of δ 116.3 (CN), 166.2 (CO) along with the signals for coumarin and thiophene carbons.
The presence of the α-bromocarbonyl moiety in compound 1 showed interesting reactivity towards thiazole formation. Thus, the reaction of compound 1 with phenylisothiocyanate and aromatic amines like either aniline, p-toluidine, 4-methoxyaniline or 4-chloroaniline gave the thiazole derivatives 5a-d, respectively. The structures of the latter products were established on the basis of their respective analytical and spectral data. Thus, the 1 H-NMR spectrum of 5a showed the presence of two singlets at δ 3.99, 6.67 ppm corresponding to thiazole H-4 and coumarin H-4 in addition to a multiplet at δ 7.43-8.58; corresponding to 2C6H5 and C6H4 protons. In addition, the 13 C-NMR spectrum revealed the presence of δ 164.3 (CO), 173.4 (C=N) beside the signals for coumarin, thiazole and 2C6H5 carbons (Scheme 1).
The multicomponent reactions of compound 1 with aromatic aldehydes and malononitrile were studied in order to generate potentially biologically active pyran and pyridine derivatives. Thus, the reaction of compound 1 with benzaldehyde, 4-methoxybenzaldehyde, 4-chlorobenzaldehyde or furfural gave the pyran derivatives 6a-d, respectively. On the other hand, carrying the same reaction but using a catalytic amount of ammonium acetate instead of triethylamine gave the pyridine derivatives 7a-d, respectively. The analytical and spectral data of 6a-d and 7a-d are consistent with their respective structures (see experimental section) (Scheme 2).
The α-bromocarbonyl moiety present in compound 1 showed high reactivity towards nucleophilic displacement reactions. Thus, compound 1 reacted with potassium cyanide in aqueous medium to give the 3-oxo-3-(2-oxo-2H-chromen-3-yl)propanenitrile (8), the structure of which was based on analytical and spectral data. Compound 8 underwent heterocyclization reactions through its reaction with different chemical reagents. Thus, it reacted with either hydrazine hydrate or phenylhydrazine to give the pyrazole derivatives 9a and 9b, respectively. On the other hand, the multicomponent reaction of compound 8 with benzaldehyde, 4-methoxybenzaldehyde, 4-chlorobenzaldehyde or furfural gave the pyran derivatives 10a-d, respectively. Alternatively, performing the same reaction but using a catalytic amount of ammonium acetate instead of triethylamine gave the pyridine derivatives 11a-d, respectively (Scheme 3).The newly synthesized products were screened against different cancer cell lines where most of them showed remarkable activities. 
In Vitro Cytotoxicity
Effect on the Growth of Human Cancer Cell Lines
The heterocyclic compounds, prepared in this study, were evaluated according to standard protocols for their in vitro cytotoxicity against six human cancer cell lines including cells derived from human gastric cancer (NUGC), human colon cancer (DLD1), human liver cancer (HA22T and HEPG2), nasopharyngeal carcinoma (HONE1), human breast cancer (MCF) and normal fibroblast cells (WI38). For comparison purposes, CHS 828, a pyridyl cyanoguanidine, was used as a standard antitumor drug ( Figure 2 ) [34] . All of the IC50 values (concentration that produces 50% reduction in cell growth) in nanomolars (nM) are listed in Table 1 . All of the synthesized compounds showed potent inhibition with IC50 values in the nM range and the results are represented graphically in All the synthesized compounds were tested for their cytotoxicity against normal fibroblast cells. The results obtained showed that normal fibroblast cells (WI38) were affected to a much lesser extent (IC50 > 10,000 nM). 
Structure Activity Relationship
In this study, when correlating the structures of the synthesized compounds with their anticancer activity, it has been observed that most of the synthesized compounds exhibited significant cytotoxic effects with IC50 values < 900 nM. Normal fibroblast cells (WI38) were affected to a much lesser extent (IC50 > 10,000 nM).
Phenylacetohydrazonoyl bromide derivative 2 was active against four cancer cell lines, namely NUGC, DLDI, HEPG2 and MCF with IC50 of 48, 60, 174 and 288 nM, respectively.
Comparing the cytotoxicity of the thiophene derivatives 4a and 4b, one can say that the cytotoxicity of 4a was higher than that of 4b. The presence of CN group with the thiophene ring in 4a was responsible for its high potency.
Among the thiazole derivatives 5a-d, compound 5d is the most active derivative. It showed high potency against NUGC, DLDI, HA22T and HONEL with IC50 of 38, 163, 120 and 441 nM, respectively. Such high potency of 5d is due to the presence of the 4-chlorophenyl moiety with the thiazole ring. The presence of p-tolyl moiety in 5b decreases the activity relative to the unsubstituted phenyl derivative 5a. On the other hand, the introduction of 4-OCH3 group in 5c revealed better cytotoxicity against DLDI and HONEL than 5a.
Considering the bromo-4H-pyran derivatives 6a-d, compounds 6c and 6d revealed higher cytotoxic activity than 6a and 6b, both of them were active against most cancer cell lines. Compound 6d showed almost equipotent activity against NUGC (IC50 = 29 nM) compared with the standard CHS 828 (IC50 = 25 nM). At the same time, 6c exhibited the highest cytotoxicity among the four derivatives against MCF with IC50 = 89 nM. The reason for the high cytotoxicity of compounds 6c and 6d was attributed to the presence of the 4-chlorophenyl and the furan moieties, respectively.
The 5-bromo-1,4-dihydropyridine derivatives 7a-d showed optimal cytotoxic activity. Compounds 7a, 7b and 7c exhibited cytotoxic activity towards the six cancer cell lines. Compound 7c incorporating with the 4-chlorophenyl moiety showed the highest potency among the four compounds with IC50 of 32 and 43 nM against DLDI and MCF, respectively. In general, the presence of the 5-bromopyridine moiety in compounds 7a-c was responsible for their high potency.
Comparing the cytotoxicity of the pyrazole derivatives 9a and 9b, it was clear that the cytotoxicity of 9a was higher than that of 9b. It was clear that the N-phenylpyrazolyl moiety in compound 9b was responsible for its lower potency.
Among the 4H-pyran-3,5-dicarbonitrile 10a-d, compounds 10c and 10d showed higher cytotoxicity than 10a and 10b. Such high potency was attributed to the presence of 4-chlorophenyl group in the case of compound 10c, and the furan moiety in case of compound 10d, together with the pyran ring.
Among the 1,4-dihydropyridine-3,5-dicarbonitrile derivatives 11a-d, compound 11b with the 4-methoxyphenyl moiety showed the highest activity among the four derivatives. Compound 11b showed high potency against NUGC, DLDI, HEPG2 and MCF cell lines with IC50 of 124, 58, 215 and 39 nM, respectively.
Comparing the cytotoxicity of the bromo-4H-pyran derivatives 6a-d and 4H-pyran-3,5-dicarbonitrile 10a-d, it was obvious that the presence of bromine atom together with the furan moiety in 6d was responsible for its higher cytotoxicity than 10d. Also the presence of a bromine atom in the 1,4-dihydropyridine derivatives 7a-c revealed higher cytotoxic activity than the 1,4-dihydropyridine-3,5-dicarbonitriles 11a-c [35, 36] .
Experimental
Chemistry
All melting points were determined on a Stuart apparatus and the values given are uncorrected. IR spectra (KBr, cm C-NMR spectra were recorded on Bruker Ascend 400 MHz spectrophotometers (Microanalytical Unit, Faculty of Pharmacy, Cairo University, Egypt) using TMS as the internal standard. Chemical shift values were recorded in ppm on δ scale. The electron impact (EI) mass spectra were recorded on a Hewlett Packard 5988 spectrometer (Microanalysis Center, Cairo University, Egypt). Elemental analyses were carried out at the Microanalysis Center, Cairo University, Egypt; found values were within ±0.35% of the theoretical ones. The progress of the reactions was monitored using thin layer chromatography (TLC) sheets precoated with UV fluorescent silica gel Merck 60F 254 and were visualized using UV lamp. The 3-(2-bromoacetyl)-2H-chromen-2-one (1) [30, 31] was obtained using the reported procedure by the reaction of 3-acetylcoumarin in chloroform solution with bromine together with continuous stirring.
To a cold solution of the 3-(2-bromoacetyl)-2H-chromen-2-one (1) (2.67 g, 0.01 mol) in ethanol (30 mL) containing sodium acetate (2.5 g), a cold solution of benzenediazonium chloride (0.01 mol) (prepared by the addition of sodium nitrite solution (0.7 g, 0.01 mol) to a cold solution of aniline (0.93 g, 0.01 mol) in concentrated hydrochloric acid (12 mL) with continuous stirring) was added while stirring. The reaction mixture was kept at room temperature for 1 h and the formed solid product was collected by filtration and crystallized from ethanol. Yield: 85%;m. 
General Procedure for the Synthesis of 4a,b
A mixture of 1 (2.67 g, 0.01 mol) in absolute ethanol (40 mL) containing triethylamine (1.0 mL) and elemental sulfur (0.32 g, 0.01 mol) and either malononitrile (0.66 g, 0.01 mol) or ethyl cyanoacetate (1.13 g, 0.01 mol) was heated under reflux for 2 h. The reaction mixture was left to cool to room temperature and the formed solid product was collected by filtration and crystallized from ethanol. 01 mol) in absolute ethanol (40 mL) containing triethylamine (1.0 mL) was heated under reflux for 2 h, left to cool to room temperature, poured onto ice/water, and neutralized by hydrochloric acid. The precipitated solid was collected by filtration, washed with water and crystallized from ethanol. or furfural (0.96 g, 0.01 mol) in absolute ethanol (40 mL) containing triethylamine (1.0 mL) was heated under reflux for 2 h, left to cool to room temperature, poured onto ice/water, and neutralized by hydrochloric acid. The precipitated solid was collected by filtration, washed with water and crystallized from ethanol. -4), 116.9 (CN), 119.3, 120.3, 121.9, 123.8, 124.5, 124.8, 125.8, 126.2,  126.9, 128.0, 128.3, 130.3, 132.4, 139.3, 140.9, 143.2 (coumarin, pyridine, C6H5 C A solution of compound 8 (2.13 g, 0.01 mol) and either hydrazine hydrate (0.5 g, 0.01 mol) or phenylhydrazine (1.08 g, 0.01 mol) in absolute ethanol (40 mL) was heated under reflux for 2 h, left to cool to room temperature, poured onto ice/water containing few drops hydrochloric acid. The resulting product was collected by filtration, washed with water and crystallized from ethanol. (WI38) were kindly provided by the National Cancer Institute (NCI, Cairo, Egypt). They were grown as a monolayer and routinely maintained in RPMI-1640 medium supplemented with 5% heat inactivated FBS, 2 mM glutamine and antibiotics (penicillin 100 U/mL, streptomycin 100 g/mL) at 37 °C in a humidified atmosphere containing 5% CO2. Exponentially growing cells were obtained by plating 1.5 × 10 5 cells/mL for the six human cancer cell lines followed by 24 h of incubation. The effect of the vehicle solvent (DMSO) on the growth of these cell lines was evaluated in all the experiments by exposing untreated control cells to the maximum concentration (0.5%) of DMSO used in each assay.
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Conclusions
The present study reports the successful synthesis, characterization and anticancer evaluation of new series of pyran, pyridine, thiophene, thiazole and pyrazole derivatives starting from 3-bromoacetylcoumarin through its reaction with different reagents. Most compounds showed potent inhibition with IC50 ˂ 900 nM. Among these derivatives, compound 6d showed almost equipotent cytotoxic activity against NUGC (IC50 = 29 nM) compared to the standard CHS 828 (IC50 = 25 nM). Normal fibroblast cells (WI38) were affected to a much lesser extent (IC50 > 10,000 nM). The results suggest that these compounds may serve as lead chemical entities for further modification in the search of new classes of potential anticancer agents.
